Journey Medical (DERM) Short-term Investments (2023)
Journey Medical's (DERM) quarterly Short-term Investments came in at $8.8 million in Q2 2023.
Journey Medical (DERM) Short-term Investments (2023) Analysis & Trends
Journey Medical (DERM) has 1 years of Short-term Investments data on file, last reported at $8.8 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Journey Medical | 202.90 Mn | 177.26 Mn | 12.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 8.75 Mn |